News
Read the latest news releases and articles from the Organ Procurement & Transplantation Network below:
OPTN Modernization
Wednesday, March 22, 2023
HRSA launched the Organ Procurement and Transplantation Network (OPTN) Modernization Initiative to better serve the needs of patients and families.
Read the press release-
OPTN policy and bylaws changes effective September 1
Friday, August 30, 2013
We updated policies, bylaws and the OPTN evaluation plan.
-
OPTN to implement new process for patient status verification
Friday, August 9, 2013
Recent interpretations of rules regarding the protection of Social Security data have limited our ability to use those data to supplement the OPTN database.
-
Vascular composite allografts to be added to OPTN final rule and federal definitions of organs
Friday, July 5, 2013
This designation is effective July 3, 2014.
-
Board addresses restoration of membership privileges, policy guidance
Tuesday, June 25, 2013
At its meeting June 24 and 25, the board restored full membership privileges to Nevada Donor Network.
-
Board approves significant revisions to deceased donor kidney allocation policy
Tuesday, June 25, 2013
The policy will maintain access to kidney transplantation for all groups of candidates while seeking to improve outcomes for kidney transplant recipients.
-
OPTN response to court order regarding Sarah Murnaghan
Tuesday, June 4, 2013
The letter is in response to a June 5, 2013 federal district court order.
-
OPTN statement regarding lung transplantation and pediatric priority
Monday, May 27, 2013
Recent media coverage has focused public attention on the needs of lung transplant candidates, especially those who are young children.
-
Officers and board members elected - 2013
Tuesday, March 12, 2013
The OPTN has elected 15 new members to its Board of Directors.
-
OPTN/SRTR publishes 2011 annual data report
Wednesday, December 19, 2012
The report publishes organ transplant statistics.
-
FDA notice relating to New England Compounding Center product recall
Wednesday, October 17, 2012
The U.S. Food and Drug Administration (FDA) advised providers not to use any products distributed by the New England Compounding Center.
Click on a page number to view more news in chronological order.